Biotechnology News and Research

RSS

Senesco to present preclinical data of SNS-01 at ASGCT Annual Meeting

Senesco Technologies, Inc. today announced that preclinical data for the Company's lead drug candidate, SNS-01, will be presented on May 20, 2010 at the American Society of Gene and Cell Therapy Annual Meeting being held at the Marriott Wardman Park Hotel in Washington, D.C. from May 17 to 22.

18 May 2010

Senesco Technologies third-quarter net loss increases to $5.28M

Senesco Technologies, Inc. today announced financial results for the three and nine months ended March 31, 2010.

18 May 2010

International Stem Cell announces strategic alliance with TAP

International Stem Cell Corporation, www.intlstemcell.com, announced today that it had entered into a strategic alliance with The Automation Partnership, www.automationpartnership.com, to automate and scale up the production of stem cell-derived human corneal tissue.

18 May 2010

Tengion reports net loss attributable to common stockholders of $14.33 per share for first-quarter 2010

Tengion Inc. today reported its financial results for the quarter ended March 31, 2010 and provided a corporate and clinical development update.

18 May 2010

Applied Biosystems Identifiler Direct and Identifiler Plus kits approved for forensic DNA laboratories

Life Technologies Corporation today announced that its Applied Biosystems Identifiler Direct and Identifiler Plus forensic kits have been approved by the United States Federal Bureau of Investigation for use by laboratories generating DNA profiles for inclusion in the National DNA Index System CODIS Database.

18 May 2010

KTH Royal Institute of Technology Stockholm, BioSilta Oy collaborate to optimise protein screening

KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.

18 May 2010

Study reviews impact of focal therapy for low-risk prostate cancer patients

In the July issue of European Urology, the scientific journal of the European Association of Urology, the significance and impact of focal therapy for low-risk cancer patients is discussed in a recent study by S. Eggener et al.

18 May 2010

Vect-Horus accentuates its leadership in delivering drugs to the central nervous system

Vect-Horus is a biotechnology company based on the scientific work of Dr. Michel Khrestchatisky and specializes in the development of peptide and pseudo-peptide-based vector molecules for drug targeting and delivery to the central nervous system (CNS).

18 May 2010

Helicos BioSciences to focus business on diagnostics markets

Helicos BioSciences Corporation announced today that, as part of the Company's previously disclosed efforts to consider alternatives to its existing long-term strategy, it is in the process of implementing a strategic shift to focus the business on the diagnostics markets. In connection with this effort, the Company has committed to a consolidation and reorganization of its operations in order to reduce operating costs.

18 May 2010

IMUC, Torrey Pines Institute identify peptides that generate CD-133 specific T-cells

ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells ("CSCs") which makes it promising for immunological targeting.

18 May 2010

Teva agrees to settle patent litigation regarding generic version of AstraZeneca's Entocort EC capsules

Teva Pharmaceutical Industries Ltd. announced today that it has entered into an agreement with AstraZeneca to settle patent litigation regarding Teva's U.S. generic version of AstraZeneca's Entocort EC (budesonide) capsules.

18 May 2010

Phase II ALSTAR trial: Talampanel is safe for ALS patients

Teva Pharmaceutical Industries Ltd. today announced results from the Phase II ALSTAR trial. The trial was designed to assess efficacy, safety and tolerability of Talampanel (a selective AMPA antagonist) in reducing disease-related functional deterioration in Amyotrophic Lateral Sclerosis patients.

18 May 2010

MorphoSys AG (DE) - AbD Serotec enters new growth area

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that its research and diagnostic antibody unit AbD Serotec is active in a new growth area.

18 May 2010

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.

18 May 2010

WaferGen Biosystems first-quarter revenues increase to $389,785

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genome analysis systems, today reported performance results for the first quarter ended March 31, 2010.

17 May 2010

Highwoods Properties, INC Research expand relationship

Highwoods Properties, Inc., the largest owner and operator of suburban office properties in the Southeast, today announced that it has expanded its relationship with INC Research®, Inc., a therapeutically focused contract research organization that conducts global clinical development programs.

17 May 2010

Berman Institute experts available for comment on direct-to-consumer marketing of genetic test kits

Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers—and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status—are invited to interview Berman Institute experts Joan Scott or Gail Javitt.

17 May 2010

Call for papers, panels and posters for 2010 Pacific Rim Summit now open

The Biotechnology Industry Organization invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers, and posters for the 2010 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This unique conference will be held Dec. 11-14, 2010 in Honolulu.

17 May 2010

Halozyme Therapeutics announces delivery of notice of breach to Baxter Healthcare

Halozyme Therapeutics, Inc. today announced the delivery of a notice of breach to Baxter Healthcare Corporation due to Baxter's failure to provide HYLENEX (hyaluronidase human injection) in accordance with the terms of the parties' existing development and supply contracts.

17 May 2010

genOway and Griffith University sign research partnership and license for olfactory stem cells technology

genOway, the biotechnology company dedicated to the development of genetically modified animal models, today reports an agreement with the Griffith University (Brisbane, Australia) on a eight-months research partnership with its Eskitis Institute for Cell and Molecular Therapies focusing on autologous olfactory adult stem cells. This research program is coupled with a world wide exclusive license to genOway for the rodent transgenic business.

17 May 2010

Biotechnology News and Research

Senesco to present preclinical data of SNS-01 at ASGCT Annual Meeting

Senesco Technologies third-quarter net loss increases to $5.28M

International Stem Cell announces strategic alliance with TAP

Tengion reports net loss attributable to common stockholders of $14.33 per share for first-quarter 2010

Applied Biosystems Identifiler Direct and Identifiler Plus kits approved for forensic DNA laboratories

KTH Royal Institute of Technology Stockholm, BioSilta Oy collaborate to optimise protein screening

Study reviews impact of focal therapy for low-risk prostate cancer patients

Vect-Horus accentuates its leadership in delivering drugs to the central nervous system

Helicos BioSciences to focus business on diagnostics markets

IMUC, Torrey Pines Institute identify peptides that generate CD-133 specific T-cells

Teva agrees to settle patent litigation regarding generic version of AstraZeneca's Entocort EC capsules

Phase II ALSTAR trial: Talampanel is safe for ALS patients

MorphoSys AG (DE) - AbD Serotec enters new growth area

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

WaferGen Biosystems first-quarter revenues increase to $389,785

Highwoods Properties, INC Research expand relationship

Berman Institute experts available for comment on direct-to-consumer marketing of genetic test kits

Call for papers, panels and posters for 2010 Pacific Rim Summit now open

Halozyme Therapeutics announces delivery of notice of breach to Baxter Healthcare

genOway and Griffith University sign research partnership and license for olfactory stem cells technology

Event guide: 3rd IMPACCT Real World Evidence Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News